Drugs by Numbers: Reaction-Driven De Novo Design of Potent and Selective Anticancer Leads-Reference-Cited by-同舟云学术

Drugs by Numbers: Reaction-Driven De Novo Design of Potent and Selective Anticancer Leads

Published:2012-11-20 Issue:17 Volume:52 Page:4676-4681
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Spänkuch Birgit,Keppner Sarah,Lange Lisa,Rodrigues Tiago,Zettl Heiko,Koch Christian P.,Reutlinger Michael,Hartenfeller Markus,Schneider Petra,Schneider Gisbert

Publisher

Wiley

Subject

General Chemistry,Catalysis

Reference38 articles.

1. Getting pharmaceutical R&D back on target

2. Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009

3. The productivity crisis in pharmaceutical R&D

4. Drug discovery in the next decade: innovation needed ASAP

5. Computer-based de novo design of drug-like molecules

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine;Communications Chemistry;2022-05-19

2. De novo Molecular Design with Generative Long Short-term Memory;CHIMIA;2019-12-18

3. Cheminformatic Analysis of Natural Product Fragments;Progress in the Chemistry of Organic Natural Products 110;2019

4. Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches;Current Medicinal Chemistry;2018-01-11

5. The hunt for antimitotic agents: an overview of structure-based design strategies;Expert Opinion on Drug Discovery;2016-04-26